Concepedia

Publication | Closed Access

Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused Ultrasound

DOI

52

Citations

0

References

2020

Year

Philipp Huber, Naveed Afzal, Manit Arya, Silvan Boxler, Tim Dudderidge, Mark Emberton, Stephanie Guillaumier, Richard Hindley, Feargus Hosking‐Jervis, Lucas Leemann,
The Journal of Urology

Abstract

Following focal high intensity focused ultrasound a prostate specific antigen nadir of 1.0 ng/ml at 12 months and 1.5 ng/ml at 24 to 36 months might be used to triage men requiring magnetic resonance imaging and biopsy. These data need prospective validation.